HealthCor Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

HealthCor Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,750,000	Closed	-$202M	–	59
2017 Q4	$202M	Sell	3,750,000 -400,000	-10%	-$21.9M	6.58%	2
2017 Q3	$237M	Sell	4,150,000 -2,325,000	-36%	-$136M	7.94%	3
2017 Q2	$390M	Buy	6,475,000 +1,475,000	+30%	+$84M	14.06%	1
2017 Q1	$272M	Buy	+5,000,000	New	+$246M	12.49%	1

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

HealthCor Management's BIVV Position: Q1 2018 in Review

HealthCor Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 3,750,000 shares — an estimated $202M sold.

HealthCor Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $390M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

HealthCor Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
HealthCor Management sold 3,750,000 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $202M.
HealthCor Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
HealthCor Management's Bioverativ Inc. Common Stock position peaked at $390M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on HealthCor Management's 13F filing for Q1 2018, filed 15 May 2018.